Balyasny Asset Management LLC Summit Therapeutics Inc. Put Options Transaction History
Balyasny Asset Management LLC
- $58 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SMMT
# of Institutions
193Shares Held
75.8MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$452 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$202 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$146 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$101 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$64.1 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.72B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...